Nelly Devuyst Cleansing Bioacne
Salicylic Acid
Laboratoires Druide Inc
Human Otc Drug
NDC 71447-003Nelly Devuyst Cleansing Bioacne also known as Salicylic Acid is a human otc drug labeled by 'Laboratoires Druide Inc'. National Drug Code (NDC) number for Nelly Devuyst Cleansing Bioacne is 71447-003. This drug is available in dosage form of Gel. The names of the active, medicinal ingredients in Nelly Devuyst Cleansing Bioacne drug includes Salicylic Acid - .7 g/100mL . The currest status of Nelly Devuyst Cleansing Bioacne drug is Active.
Drug Information:
| Drug NDC: | 71447-003 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Nelly Devuyst Cleansing Bioacne |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Salicylic Acid |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Laboratoires Druide Inc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Gel |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | SALICYLIC ACID - .7 g/100mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 26 May, 2018 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 08 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part333D |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | LABORATOIRES DRUIDE INC
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 2043457
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0829852190215
0829852190222
|
| UPC stands for Universal Product Code. |
| UNII: | O414PZ4LPZ
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 71447-003-01 | 1 BOTTLE, SPRAY in 1 CARTON (71447-003-01) / 500 mL in 1 BOTTLE, SPRAY | 26 May, 2018 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose acne treatment
Product Elements:
Nelly devuyst cleansing bioacne salicylic acid lime oil glycerin silver citrate michelia alba leaf oil carboxymethylcellulose arctium lappa root oil tea tree oil citrus aurantium fruit oil potassium sorbate citric acid monohydrate magnolia officinalis bark arginine coco glucoside lavandula angustifolia flower sodium gluconate levulinic acid xanthan gum water salicylic acid salicylic acid aloe vera leaf urtica dioica leaf propanediol sodium levulinate levulinic acid lavandin oil
Indications and Usage:
Uses reduces the number and or severity of acne pimples.
Warnings:
Warnings for external use only .
When Using:
When using this product ⪠avoid contact with eyes. if contact occurs, rinse thoroughly with water ⪠skin irritation and dryness are more likely to occur when using another topical acne product at the same time. if irritation occurs, use only one product at a time.
Dosage and Administration:
Directions ⪠for new users: apply product to a small area once to test if you are sensitive to this product. ⪠if no discomfort occurs, product can be used in the morning and or evening. ⪠apply product to wet hands and rub well over entire face. ⪠rinse well with water until all traces of cleanser are removed. ⪠if bothersome dryness, irritation or peeling occurs, reduce application to every other day.
Stop Use:
Stop use
Package Label Principal Display Panel:
Nelly devuyst cleansing gel bioacne 16.90 fl.oz (500ml) (71447-003-01) nelly devuyst cleansing gel bioacne 500ml cleansinggelbioacnelabel
Further Questions:
Questions or comments? call +1 800-263-8888 outside canada or united states, dial +1 514-333-8282, or visit www.nellydevuyst.com